Search results for:
delandistrogene moxeparvovec
delandistrogene moxeparvovec
| Drug Name |
Form |
Strength |
ARHS |
Blue Ridge |
Caldwell |
Chatham |
Johnston |
Lenoir |
Medical Center |
Nash |
Pardee |
Rex |
Rockingham |
Southeastern |
Wayne |
Youth Behavioral Health |
| Elevidys (10-10.4 kg) |
KIT, INTRAVENOUS |
rokl |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| delandistrogene moxeparvovec-rokl |
KIT, INTRAVENOUS |
1.33 × 10^13 vector genomes/mL (10 mL) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Last updated: Aug. 24, 2026
UNC Health
System Formulary Restriction:
Elevidys is restricted to the following:
prior to administration
Caution – Category 1: Antineoplastic Hazardous Medication, see below for exposure mitigation strategies
Med Center
UNC Medical Center Formulary Restrictions